In the LimeLight: AskBio names gene therapy pioneer as president for therapeutics
AskBio, a clinical-stage adeno-associated virus (AAV) gene therapy company and wholly owned subsidiary of Bayer AG, today announced that Katherine High has joined the company in the newly formed role of President, Therapeutics and will also serve on its Board of Directors.
Read More